1996
DOI: 10.1159/000462047
|View full text |Cite
|
Sign up to set email alerts
|

Production and Characterization of a Reconstituted High Density Lipoprotein for Therapeutic Applications

Abstract: A method is described for the large scale preparation of reconstituted high density lipoproteins (rHDL) suitable for therapeutic use. Apolipoprotein A-I (apoA-I) was isolated from precipitates obtained by cold ethanol fractionation of human plasma. This process includes several steps for virus removal and virus inactivation, among them pasteurization. Reconstitution of lipoprotein particles was performed by cholate dialysis using soybean phosphatidylcholine as the lipid source. An apoA-I:lipid ratio of 1:150 (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
82
1

Year Published

2001
2001
2021
2021

Publication Types

Select...
8
1
1

Relationship

3
7

Authors

Journals

citations
Cited by 84 publications
(86 citation statements)
references
References 47 publications
3
82
1
Order By: Relevance
“…The homogeneity and size of the reconstituted lipoprotein complexes were assessed by size exclusion chromatography and native-PAGE, as described below, and by negative staining electron microscopy (25). Electron microscopy analysis of our rHDL preparation revealed characteristic disc shaped structures (average diameter: 15 nm), similar to those found in the literature for rHDL (22,(26)(27)(28).…”
Section: Making Of Liposomessupporting
confidence: 68%
“…The homogeneity and size of the reconstituted lipoprotein complexes were assessed by size exclusion chromatography and native-PAGE, as described below, and by negative staining electron microscopy (25). Electron microscopy analysis of our rHDL preparation revealed characteristic disc shaped structures (average diameter: 15 nm), similar to those found in the literature for rHDL (22,(26)(27)(28).…”
Section: Making Of Liposomessupporting
confidence: 68%
“…2,3 Then, infusions of ACh and SNP were repeated. In further 5 hypercholesterolemic patients, the effects of intravenous rHDL infusion on ACh-and SNP-induced vasodilation were assessed during intraarterial coinfusion of N G -monomethyl-L-arginine (L-NMMA, 4 mol/min; Clinalfa), an inhibitor of NO synthase.…”
Section: · Minmentioning
confidence: 99%
“…Then, a venous catheter was inserted in the contralateral arm for systemic administration of apoA-I/PC disks at a dose of 80 mg/kg body weight over a period of 4 hours (ZLB Bioplasma AG). 19,20 Subsequently, all 3 infusion blocks were repeated.…”
Section: Study Protocolmentioning
confidence: 99%